Cargando…

Vitamin D as a Potential Therapy for Multiple Sclerosis: Where Are We?

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system and is caused by an aberrant immune response to myelin sheath. Disease-modifying medications, which mainly aim to suppress such aberrant immune response, have significantly improved MS treatment. However, the di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wasnik, Samiksha, Sharma, Isha, Baylink, David J., Tang, Xiaolei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247155/ https://www.ncbi.nlm.nih.gov/pubmed/32354174 http://dx.doi.org/10.3390/ijms21093102

Ejemplares similares

Inflammation- and Gut-Homing Macrophages, Engineered to De Novo Overexpress Active Vitamin D, Promoted the Regenerative Function of Intestinal Stem Cells
por: Xu, Yi, et al.
Publicado: (2021)

Towards Clinical Translation of CD8(+) Regulatory T Cells Restricted by Non-Classical Major Histocompatibility Complex Ib Molecules
por: Wasnik, Samiksha, et al.
Publicado: (2019)

A novel vitamin D gene therapy for acute myeloid leukemia
por: Xu, Yi, et al.
Publicado: (2020)

Mechanistic study of the cause of decreased blood 1,25-Dihydroxyvitamin D in sepsis
por: Li, Chih-Huang, et al.
Publicado: (2019)

The Effects of Insulin-Like Growth Factor I and BTP-2 on Acute Lung Injury
por: Munoz, Kevin, et al.
Publicado: (2021)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Effect of aging on stem cells
por: Ahmed, Abu Shufian Ishtiaq, et al.
Publicado: (2017)

Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
por: Dörr, Jan, et al.
Publicado: (2013)

Vitamin D and multiple sclerosis: Potential pathophysiological role and clinical implications
por: Dudani, Sharmila J, et al.
Publicado: (2011)

IGF-1 Deficiency Rescue and Intracellular Calcium Blockade Improves Survival and Corresponding Mechanisms in a Mouse Model of Acute Kidney Injury
por: Wasnik, Samiksha, et al.
Publicado: (2020)

Vitamin D and multiple sclerosis
por: Harandi, Asghar Amini, et al.
Publicado: (2014)

Vitamin D for COVID-19: where are we now?
por: Martineau, Adrian R., et al.
Publicado: (2022)

Vitamin E: Where Are We Now in Vascular Diseases?
por: Garg, Anahita, et al.
Publicado: (2022)

Cyclooxygenase 2 augments osteoblastic but suppresses chondrocytic differentiation of CD90(+) skeletal stem cells in fracture sites
por: Wasnik, Samiksha, et al.
Publicado: (2019)

Unique anabolic action of stem cell gene therapy overexpressing PDGFB-DSS6 fusion protein in OVX osteoporosis mouse model
por: Chen, Wanqiu, et al.
Publicado: (2019)

Dendritic cells, engineered to overexpress 25-hydroxyvitamin D 1α-hydroxylase and pulsed with a myelin antigen, provide myelin-specific suppression of ongoing experimental allergic encephalomyelitis
por: Li, Chih-Huang, et al.
Publicado: (2017)

Update in vitamin D and multiple sclerosis
por: Alharbi, Fatimah M.
Publicado: (2015)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
por: Sidoroff, Victoria, et al.
Publicado: (2022)

Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats
por: Feige, Julia, et al.
Publicado: (2020)

Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go?
por: Morè, Sonia, et al.
Publicado: (2022)

The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19
por: Xu, Yi, et al.
Publicado: (2020)

Vitamin D and Multiple Sclerosis: A Comprehensive Review
por: Sintzel, Martina B., et al.
Publicado: (2017)

The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update
por: Sangha, Amarpreet, et al.
Publicado: (2023)

Linking Mechanisms of Vitamin D Signaling with Multiple Sclerosis
por: Carlberg, Carsten, et al.
Publicado: (2023)

Animal Sentience: Where are We and Where are We Heading?
por: Proctor, Helen
Publicado: (2012)

Bioactive Glasses: Where Are We and Where Are We Going?
por: Baino, Francesco, et al.
Publicado: (2018)

Diabetic cardiomyopathy: where we are and where we are going
por: Lee, Wang-Soo, et al.
Publicado: (2017)

Hidradenitis Suppurativa: Where We Are and Where We Are Going
por: Scala, Emanuele, et al.
Publicado: (2021)

Interstitial lung disease in systemic sclerosis: where do we stand?
por: Cappelli, Susanna, et al.
Publicado: (2015)

Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis
por: Goischke, Hans-Klaus
Publicado: (2019)

Patient Experience in Home Respiratory Therapies: Where We Are and Where to Go
por: Caneiras, Cátia, et al.
Publicado: (2019)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Vitamin D and Multiple Sclerosis: Correlation, Causality, and Controversy
por: Smolders, Joost
Publicado: (2010)

What is the Real Fate of Vitamin D in Multiple Sclerosis?
por: Shaygannejad, Vahid, et al.
Publicado: (2013)

An Update on Vitamin D and Disease Activity in Multiple Sclerosis
por: Smolders, Joost, et al.
Publicado: (2019)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Stem Cell Therapy in Bladder Dysfunction: Where Are We? And Where Do We Have to Go?
por: Kim, Jae Heon, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e1dva2tgj4me076hbgmgabfme4